Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05389956

Identification of Risk Factors for Cardiovascular Disease and Cancer in Korean Population: A Prospective Cohort Study

Cancer and cardiovascular disease are the global leading causes of death. These two disease entities are multifactorial disease that are caused by several factors. The aim of this prospective cohort study was to investigate the status of risk factors profiles and health related behavior in Korean population, and to discover novel risk factors associated with the occurrence of endpoint events.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cardiovascular Diseases Malignancy Neoplasms Risk Factor

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ulsan University Hospital

Ulsan, 44033, South Korea

Location status: Recruiting

Location contact

Sangwoo Park, MD

CONTACT

[email protected]

Sangwoo Park, MD

PRINCIPAL_INVESTIGATOR

About this study

This is a single center, observational, prospective cohort study. The primary outcomes include the incidence of MACE (major adverse cardiovascular events) and the incidence of any malignancy. We plan to collect the baseline information at enrollment and the occurrence of clinical endpoint events will be followed for at least 10 years. The study will enroll 510,000 subjects aged ≥19 years who underwent a general health screening in Korea.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men or women aged 19 years and older who underwent a general health screening at the health promotion center of Ulsan University Hospital (Ulsan, Korea)
  • Subjects have to agree to participate by signing a consent

Exclusion criteria

  • Subjects who cannot or reject to sign the consent form.

Treatment and study plan

Primary outcomes

  1. Major adverse cardiovascular event (MACE)

    Time frame: 10 year

    A major adverse cardiovascular event (MACE) of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke

  2. Incidence of malignancy

    Time frame: 10 year

    The occurrence of any malignancy of interest

Secondary outcomes

  1. All-cause death

    Time frame: 10 year

  2. Cardiovascular death

    Time frame: 10 year

  3. Myocardial infarction

    Time frame: 10 year

  4. Stroke

    Time frame: 10 year

  5. Cancer related mortality

    Time frame: 10 year

Study contacts

Contact information is provided by the study sponsor or research team.

Sangwoo Park, MD

CONTACT

[email protected]

82-52-250-8669

Sponsors and collaborators

Lead sponsor

Ulsan University Hospital

Other

Registry information

Important dates

Study start
2023
Primary completion
2042
Study completion
2052
First posted
May 25, 2022
Registry last updated
Mar 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.